Notice of Closed Meeting, 76575 [2020-26256]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 230 / Monday, November 30, 2020 / Notices
Total Estimated Annual Burden: 5
hours.
General Description of Collection:
Assets held by the FDIC in the course
of liquidating any covered financial
company must not be sold to persons
who contributed to the demise of a
covered financial company in specified
ways (e.g., individuals who profited or
engaged in wrongdoing at the expense
of the failed institution, or seriously
mismanaged the failed institution). 12
CFR part 380 requires prospective
purchasers to complete and submit a
Purchaser Eligibility Certification (PEC)
to the FDIC. The PEC is a self
certification by a prospective purchaser
that it does not fall into any of the
categories of individuals or entities that
are prohibited by statute or regulation
from purchasing the assets of covered
financial companies. The PEC will be
required in connection with the sale of
assets by the FDIC, as receiver for a CFC,
or the sale of assets by a BFC which
requires the approval of the FDIC, as
receiver for the predecessor CFC and as
the sole shareholder of the BFC. There
is no change in the methodology or
substance of this information collection.
The estimated annual burden is
unchanged.
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than December 15, 2020.
Request for Comment
Comments are invited on: (a) Whether
the collection of information is
necessary for the proper performance of
the FDIC’s functions, including whether
the information has practical utility; (b)
the accuracy of the estimates of the
burden of the information collection,
including the validity of the
methodology and assumptions used; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. All comments will become
a matter of public record.
A. Federal Reserve Bank of Kansas City
(Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. The Trevor C. McNeill Revocable
Trust B, Trevor McNeill, as trustee,
Dallas, Texas; to acquire voting shares
of Bank of Wyandotte, Wyandotte,
Oklahoma.
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on November 24,
2020.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2020–26323 Filed 11–25–20; 8:45 am]
TKELLEY on DSKBCP9HB2PROD with NOTICES
BILLING CODE 6714–01–P
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
VerDate Sep<11>2014
20:03 Nov 27, 2020
Jkt 253001
Board of Governors of the Federal Reserve
System, November 24, 2020.
Michele Taylor Fennel,
Deputy Associate Secretary of the Board.
[FR Doc. 2020–26351 Filed 11–27–20; 8:45 am]
BILLING CODE P
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Frm 00062
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Date: February 17–18, 2021.
Time: 11:00 a.m.–5:00 p.m., EST.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
study section to consider safety and
occupational health-related grant
applications.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, 1095
Willowdale Road, Morgantown, WV
26506, (304) 285–5951; MGoldcamp@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–26256 Filed 11–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
76575
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 85, Number 230 (Monday, November 30, 2020)]
[Notices]
[Page 76575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26256]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
Date: February 17-18, 2021.
Time: 11:00 a.m.-5:00 p.m., EST.
Place: Teleconference.
Agenda: The meeting will convene to address matters related to the
conduct of Study Section business and for the study section to consider
safety and occupational health-related grant applications.
FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, WV 26506,
(304) 285-5951; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-26256 Filed 11-27-20; 8:45 am]
BILLING CODE 4163-18-P
